Preparation of medication based on extracts obtained from Salviae miltiorrhizae root and Notoginseng root for use in the treatment of cardiovascular and cerebrovascular diseases, characterized in that the extracts comprise: ** Formula ** in which R1 is and R2 is, in the that the drug preparation has the physical and chemical parameters characterized as follows: in the HPLC spectrum, there are 8 peaks that have an individual peak area ratio with respect to total peak area greater than 2%； The average retention time of these 8 peaks is 6.04, 9.90, 16.89, 17.84, 20.31, 23.74, 27.73 and 31.02 respectively, the% of DER of the time The retention rate is 0.31, 0.25, 0.61, 0.70, 0.96, 0.76, 0.50 and 1.18 respectively； the average peak area is 1627.92, 2575.54, 366.89, 381.40, 186.08, 555.35, 281.91 and 1852.33 respectively, the% of DER of the peak area is 5.91, 13.53, 10.92, 13.81, 12.04, 10.48, 18.08 and 14.84, respectively； and the range of the ratio of individual peak area with respect to total peak area represents 19.6% -22.0%, 28.5-37.4%, 4.2% -5.2%, 4 , 2% - 5.5%, 2.1% -2.7%, 6.4% -7.8%, 3.0% -4.3% and 20.2% -27.2% respectively； wherein the above physical and chemical parameters are determined under the following conditions: (1) high performance liquid chromatography: charge: octadecylsilyl silica gel； flow rate: 1,000 ml / min； and detection wavelength: 280 nm； and (2) elution: mobile phase A: 0.02% aqueous phosphoric acid solution； mobile phase B: 0.02% aqueous phosphoric acid solution - 80% acetonitrile； and gradient elution: changing the mobile phase A from 90% to 78% homogeneously and changing the mobile phase B from 10% to 22% homogeneously for 0 to 8 min, the mobile phase A from 78% to 74% and mobile phase B from 22% to 26% for 8 to 15 min, and mobile phase A from 74% to 48% and mobile phase B from 26% to 52% during from 15 to 55 min； and in which the sample solution is prepared and determined through the following steps of: weighing tablets of the drug prepara
